Price

rebased to 0%

ADMA, solidAMGN, dashed

ADMAAdma Biologics, Inc.

13.21· pre 13.04· delayed

Mkt cap$2.3BRevenue$141MQ3 FY26Revenue$510MFY25

AMGNAmgen Inc

461.49· pre 450.62· delayed

Pre-marketNov 6 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

vs

Compare

Pre-marketNov 6 '26delayed

ADMAAdma Biologics, Inc.

vs

AMGNAmgen Inc

13.21pre 13.04delayed

Price

461.49pre 450.62delayed

$2.3B

Mkt cap

$249.0B

Q3 FY26$141M

Revenue

$10.4BQ3 FY26

FY25$510M

Revenue

$36.8BFY25

ADMA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name